Christopher G. Hayes, Chief Legal Officer at Verrica Pharmaceuticals Inc. (VRCA), sold 55,840 shares at $2.93 ($164K) on 2023-11-14, disclosed to the SEC on 2023-11-16.
Open-market sale of $164k VRCA by Chief Legal Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.93 | 22,141 | $65K | 39.5% |
| 2 | $2.93 | 22,141 | $65K | 39.5% |
| 3 | $2.97 | 11,558 | $34K | 20.9% |
| Total | $2.94 avg | 55,840 | $164K | 100% |
| Filing → |
| VRCA | SELL | 2024-07-23 | $306K | — | Filing → |
| VRCA | SELL | 2023-07-25 | $326K | — | Filing → |
| VRCA | BUY | 2022-07-11 | $26K | — | Filing → |